Breaking Travel News

JTC to Invite International Proposals for Hotel Development

JTC Corporation (JTC)—
Singapore’s leading industrial developer and master planner—will launch
Request-for-Proposals (RFPs) for its business hotel and Biopolis Phase 2
(a biomedical multi-tenanted building) developments in one-north,
Singapore, on 29 September 2004. International property and real estate
developers are invited to submit proposals to build, own and operate these
two latest developments in the 200-hectare one-north technology and
innovations hub. The RFPs will close on 12 November 2004 and 12 January
2005 for the Biopolis Phase 2 and hotel projects respectively. Business Hotel at Vista Xchange

JTC has identified a site covering 4,000 sqm for the development of a
business hotel. The hotel is located within walking distance of a Mass
Rapid Transit station, the Biopolis biomedical hub and the upcoming hub
for the Infocomms and Media industries—Fusionpolis. The site can
accommodate approximately 18,800 sqm of gross floor area, and the hotel
can have up to 350 rooms.

As part of the mixed-use development in one-north, JTC is inviting private
developers to participate in an integrated business hotel development. To
facilitate such a total development concept, the business hotel site comes
with an adjacent 0.89-hectare ‘white’ site(1), called the ‘South Park
Quadrant’, in the RFP.

    (1) ‘White sites’ are areas used or intended to be used for commercial,
hotel, residential, sports & recreational and other compatible uses,
or a combination of two or more of such uses as a mixed use

The South Park Quadrant site has a plot ratio of 6.0 and a maximum gross
floor area of 53,400 sqm with guidelines for an experimental mix of uses
including retail, leisure, civic & community, residential and a limited
commercial quantum. It presents opportunities for an innovative mixed-use
development to complement the main hotel development.


Biopolis Phase 2

Targeted primarily at private biomedical companies, the multi-tenanted
Biopolis building will serve to meet future biomedical space needs. The
site covers 0.8 hectares and will yield 37,000 sqm of gross floor area.

Biopolis is a purpose-built biomedical research hub where researchers from
the public and private sectors are co-located. The seven-building Biopolis
Phase 1 is about 90% occupied presently. Two buildings are dedicated to
private biomedical companies while the other five house public research